FI60235C - Foerfarande foer framstaellning av tumoercelltillvaext inhiberande ks-2-a substans - Google Patents

Foerfarande foer framstaellning av tumoercelltillvaext inhiberande ks-2-a substans Download PDF

Info

Publication number
FI60235C
FI60235C FI780947A FI780947A FI60235C FI 60235 C FI60235 C FI 60235C FI 780947 A FI780947 A FI 780947A FI 780947 A FI780947 A FI 780947A FI 60235 C FI60235 C FI 60235C
Authority
FI
Finland
Prior art keywords
substance
mice
acid
buffer
minutes
Prior art date
Application number
FI780947A
Other languages
English (en)
Finnish (fi)
Other versions
FI60235B (fi
FI780947A (fi
Inventor
Nakao Ishida
Hiroshi Maeda
Fujio Suzuki
Toshikatsu Fujii
Ituro Mizutani
Original Assignee
Kirin Seagram Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3594477A external-priority patent/JPS53121919A/ja
Priority claimed from JP10632177A external-priority patent/JPS5441801A/ja
Application filed by Kirin Seagram Ltd filed Critical Kirin Seagram Ltd
Publication of FI780947A publication Critical patent/FI780947A/fi
Publication of FI60235B publication Critical patent/FI60235B/fi
Application granted granted Critical
Publication of FI60235C publication Critical patent/FI60235C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/811Interferon

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Claims (13)

1. Elementalanalys C: 39,5 *, H: 6,5 N: 1,1 £ aska: sp&r (0,4 #);
2. Molekylvikt 9000 - 3000 (genom ultrafiltrering) 7000 - 9000 (genom jämnviktstäthetsgradient centrifugering) 8000 - 3000 (med fluorescein polarieationsmetod) ;
3. Utseende amorft vitt pulver;
4. Sönderdelningspunkt 185°C (baserat p& mätning av bryningstemperaturen med kapil-larmetod under användning av kiselolja);
5. UV-spektrum Ingen egentlig maximalabsorption observerad (fig. 1)}
6. IR-spektrum (fig. 2) ;
7. Pg för vattenlösning av substansen är 7,25;
8. Löslighet Löslig i vatten, olöslig i etanol, aceton, n-hexan, n-butanol, fenol och andra organiska lösningsmedel;
9. Optiak vridning M l5 = +67,5 ± 2,0°(i H20), (C = 0,452 *);
10. Homogenitet a. Resultatet av centrifugering medenlinjär gradient av 5-20 % CsCl i o,1 M Tris-HCl buffert (pg 7,2) vid omloppstalet 38,000 varv/min och 4°C under 15 min visar att substansen är homogen (fig. 3); jämförande sedimenteringsförsök med virus-nuklein-syra visar att substansen icke innehäller viruspartiklar, RNA eller DNA; b. Substansen är elektroforetiskt homogen enligt fig. 4, som utvisar resultatet av elektrofores p& cellulosaacetat under användning av 0,1 M ättiksyra/pyridin buffert (p^ 3,5), varvid kondroitinaulfat användes som kontroll; 30 minuter efter 23 60235 elektroforesen vid 0,6 mA/cm och 160 V rör sig kondroitin-sulfatet tili katoden med en rörlighet av 4 cm per 30 min , raedan KS-2-A rör sig i nägon m&n tili anoden pä 90 min (en rörlighet av 1 cm per 90 min); substansen bar ocksä visat sig vara homogen genom elektrofores utförd under samma betingelser som ovan förutom att 1 M pyridin/ättiksyra buffert (pjj 7*0) användes;
11. Färgreaktion Fenol-H2S0^ reaktion positiv Antron reaktion ” Molisch’ reaktion " Elson-Morgens reaktion negativ Karbazol-HgO^ reaktion positiv Reaktion med Folin-Giocalteam " Biuret reaktion " Reaktion med FITC (fluorescein isotiocyanat) " Toluidin bldtt 0 färgning negativ Ninhydrin reaktion positiv
12. Sockerkomposition' Fig. 5 visar resultatet av att l&ta substansen undergä syra-hydrolys och päföljande reduktion med natriumborhydrid, sedan acetylering, varefter sockerkompositionen bestämdes genom gas-kromatografi; substansen bestär huvudsakligen av mannos och inneh&ller sm& mängder glukos och galaktos samt även mycket smä. mängder arabinos och xylos, varvid viktförh&llandena mellan dessa substanser är 74 s 12 s 12 : 1 : 1 ;
13. Aminosyrakomposition aminosyraanalys, som utförts i automatisk aminosyraanalysa-tor, genom att 10 mg av substansen inneslöts i vakuum till-sammans med 3 ml 6 N HC1 och underkastades syraanalys vid 110°C under 22 timmars tid, varefter HOI avlägsnades med roterande indunstare, visar att de i substansen befintliga aminosyrorna utgörs huvudsakligen av treonin, serin, glu-taminsyra och alanin samt dessutom sm& mängder av aspara-ginsyra, prolin, glycin, valin och lysin; vidare ndgongAng spärmängder av metionin, isoleucin, leuoin, tyrosin, fenyl-alanin, histidin, arginin och cystin;
FI780947A 1977-03-30 1978-03-29 Foerfarande foer framstaellning av tumoercelltillvaext inhiberande ks-2-a substans FI60235C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3594477 1977-03-30
JP3594477A JPS53121919A (en) 1977-03-30 1977-03-30 Interferon inducing agent containing polysaccharide mainly
JP10632177 1977-09-06
JP10632177A JPS5441801A (en) 1977-09-06 1977-09-06 Kss22a

Publications (3)

Publication Number Publication Date
FI780947A FI780947A (fi) 1978-10-01
FI60235B FI60235B (fi) 1981-08-31
FI60235C true FI60235C (fi) 1981-12-10

Family

ID=26374963

Family Applications (1)

Application Number Title Priority Date Filing Date
FI780947A FI60235C (fi) 1977-03-30 1978-03-29 Foerfarande foer framstaellning av tumoercelltillvaext inhiberande ks-2-a substans

Country Status (6)

Country Link
US (1) US4163780A (sv)
CH (1) CH641204A5 (sv)
DE (1) DE2813353A1 (sv)
FI (1) FI60235C (sv)
FR (1) FR2385734A1 (sv)
GB (1) GB1572074A (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3071750D1 (en) * 1979-07-04 1986-10-16 Kureha Chemical Ind Co Ltd Nasal preparations, process for making same and their use
JPS5712999A (en) * 1980-06-25 1982-01-22 Chiyokichi Iizuka Antibiral agent and its preparation
US4512972A (en) * 1980-06-30 1985-04-23 Kureha Chemical Industry Co., Ltd. Nasal preparation and processes for their production
WO1982003771A1 (fr) * 1981-04-30 1982-11-11 Mitsuhashi Susumu Polysaccharide ps-a isole a partir de la plante appartenant au genre epidemium violaceum morr. et decne., procede de preparation, et agent de prevention de l'infection et stimulateur de l'immunite contenant le polysaccharide a titre d'ingredient efficace
EP0384798B1 (en) * 1989-02-06 1993-08-11 Gen-Ichiro Soma Limulus test-positive plant glycolipid, and method of stimulating the immuno system of an animal
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US6975892B2 (en) * 2003-10-21 2005-12-13 Oculir, Inc. Methods for non-invasive analyte measurement from the conjunctiva
US6958039B2 (en) * 2003-05-02 2005-10-25 Oculir, Inc. Method and instruments for non-invasive analyte measurement
US6968222B2 (en) 2003-05-02 2005-11-22 Oculir, Inc. Methods and device for non-invasive analyte measurement
US20060224057A1 (en) * 2003-10-21 2006-10-05 Oculir, Inc. Methods for non-invasive analyte measurement
US20080009688A1 (en) * 2004-04-14 2008-01-10 Oculir, Inc. Methods for non-invasive analyte measurement
US20060258919A1 (en) * 2004-04-14 2006-11-16 Oculir, Inc. Non-Invasive Analyte Measurement Device for Measuring Tears and Other Ocular Elements Using Electromagnetic Radiation and Method of Using the Same
CA2574060C (en) * 2004-07-16 2019-06-25 Medimush A/S Immune modulating compounds from fungi
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
EP1885866A1 (en) * 2005-05-13 2008-02-13 Medimush A/S Feed or food products comprising fungal material
WO2006133707A2 (en) * 2005-06-15 2006-12-21 Medimush A/S Anti-cancer combination treatment and kit-of-part

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757248A (fr) * 1969-10-15 1971-04-08 Kureha Chemical Ind Co Ltd Substance a propriete anticancereuse et procedes pour sa preparation

Also Published As

Publication number Publication date
GB1572074A (en) 1980-07-23
FR2385734A1 (fr) 1978-10-27
FI60235B (fi) 1981-08-31
DE2813353A1 (de) 1978-10-19
FR2385734B1 (sv) 1981-10-30
CH641204A5 (fr) 1984-02-15
US4163780A (en) 1979-08-07
FI780947A (fi) 1978-10-01

Similar Documents

Publication Publication Date Title
FI60235C (fi) Foerfarande foer framstaellning av tumoercelltillvaext inhiberande ks-2-a substans
US4276282A (en) Interferon and preparations containing interferon
US4533548A (en) Acidic polysaccharide CH-1 isolated from Chlorella pyrenoidosa and the use thereof
US4124702A (en) Polynucleotides active as inducers of interferon production in living animal cells
FI74474B (fi) Foerfarande foer framstaellning av nya, ur klebsiella pneumoniae extraherade glykoproteiner.
FI72143C (sv) Förfarande för framställning av människointerferon.
US4247541A (en) Ks-2-b
HU176828B (en) Process for producing nitrogen-containing polysaccharides of tumor-inhibiting activity
CA1339308C (en) Polysaccharides and antiviral drug containing polysaccharides as active ingredient
EP0286869B1 (de) Verfahren zur Herstellung von Zellwandkomponenten aus Halobakterien und deren Verwendung als Arzneimittel
JPS5973519A (ja) スワインソニンの製造法およびそれを含む免疫調整剤
EP0491114B1 (en) A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity
EP0331821B1 (en) Antiviral agent
US7375230B2 (en) Fermentation and purification of migrastatin and analog
JPS58318B2 (ja) 制癌性物質の製造方法
GB2042555A (en) Interferon inducers, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments
SU897099A3 (ru) Способ получени вещества кS-2-а,обладающего противоопухолевым и антимикробным действием
IL29066A (en) Pharmaceutical preparations containing multi-chain poly-nucleotides to encourage interferon production in humans, animals or cell cultures
EP0308279A1 (fr) Nouveaux polysaccharides hydrosolubles, leur procédé d'obtention, leur application à titre de médicaments et préparation les renfermant
JPS6152807B2 (sv)
US4221705A (en) Novel peptide type antibiotic and the process for the production thereof
JPS62130B2 (sv)
JP2522945B2 (ja) 抗レトロウィルス剤
GB2042558A (en) Interferon inducers, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments
CN1209132A (zh) 由二氧化三碳单元制成的大环化合物

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: KIRIN-SEAGRAM LIMITED